Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Estimates of the rate of infection and asymptomatic COVID-19 disease in a population sample from SE England
Philippa M. Wells, Katie J. Doores, Simon Couvreur, et al.
Journal of Infection (2020) Vol. 81, Iss. 6, pp. 931-936
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
European Journal of Epidemiology (2020) Vol. 35, Iss. 12, pp. 1123-1138
Open Access | Times Cited: 804
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19
Thomas Struyf, Jonathan J Deeks, Jacqueline Dinnes, et al.
Cochrane library (2022) Vol. 2022, Iss. 5
Open Access | Times Cited: 166
Current and innovative methods for the diagnosis of COVID‑19 infection (Review)
Luca Falzone, Giuseppe Gattuso, Aristidis Tsatsakis, et al.
International Journal of Molecular Medicine (2021) Vol. 47, Iss. 6
Open Access | Times Cited: 138
Nursing homes during the COVID-19 pandemic: a scoping review of challenges and responses
Shamik Giri, Lee Minn Chenn, Román Romero‐Ortuño
European Geriatric Medicine (2021) Vol. 12, Iss. 6, pp. 1127-1136
Open Access | Times Cited: 109
Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 58
SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
Rebecca Grant, Timothée Dub, Xanthi Andrianou, et al.
BMJ Open (2021) Vol. 11, Iss. 4, pp. e045425-e045425
Open Access | Times Cited: 49
Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico
Ana Basto‐Abreu, Martha Carnalla, Leticia Torres‐Ibarra, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Seroprevalence of SARS-CoV-2 in Niger State: A Pilot Cross Sectional Study
Hussaini Majiya, Mohammed Aliyu‐Paiko, Tochukwu Vincent Balogu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 48
High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector
Maria V. Sinegubova, Н. А. Орлова, С. В. Ковнир, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0242890-e0242890
Open Access | Times Cited: 38
Seroprevalence of SARS-CoV-2 in Niger State: Pilot Cross-Sectional Study
Hussaini Majiya, Mohammed Aliyu‐Paiko, Tochukwu Vincent Balogu, et al.
JMIRx Med (2023) Vol. 4, pp. e29587-e29587
Open Access | Times Cited: 11
The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review
Natasha Marcella Vaselli, Daniel Hungerford, B. Shenton, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0250541-e0250541
Open Access | Times Cited: 28
SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges
Andrew R. McGill, Roukiah Khalil, Rinku Dutta, et al.
Infectious Disease Reports (2021) Vol. 13, Iss. 1, pp. 102-125
Open Access | Times Cited: 27
The prognostic value of general laboratory testing in patients with COVID‐19
Zhihua Lv, Wei Wang, Bin Qiao, et al.
Journal of Clinical Laboratory Analysis (2020) Vol. 35, Iss. 2
Open Access | Times Cited: 27
SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study
Antoine Lewin, Roseline Therrien, Gaston De Serres, et al.
Can J Public Health (2021) Vol. 112, Iss. 4, pp. 576-586
Open Access | Times Cited: 22
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study
Xavier Sáez‐Llorens, Claudio F. Lanata, Elaine Aranguren, et al.
Vaccine X (2022) Vol. 11, pp. 100189-100189
Open Access | Times Cited: 14
Disentangling post-vaccination symptoms from early COVID-19
Liane S. Canas, Marc F. Österdahl, Jie Deng, et al.
EClinicalMedicine (2021) Vol. 42, pp. 101212-101212
Open Access | Times Cited: 18
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March–August, 2020
Travis Lim, Mark J. Delorey, Nicolette Bestul, et al.
Clinical Infectious Diseases (2021) Vol. 73, Iss. 10, pp. 1831-1839
Open Access | Times Cited: 16
Systems dynamics and the uncertainties of diagnostics, testing and contact tracing for COVID-19
Jeanne M. Fair, Rene J. LeClaire, Lori R. Dauelsberg, et al.
Methods (2021) Vol. 195, pp. 77-91
Open Access | Times Cited: 16
Proceedings of the 2021 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies: Demonstrations

(2021)
Open Access | Times Cited: 16
Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
Engy Mohamed El‐Ghitany, Mona H. Hashish, Azza Galal Farghaly, et al.
Tropical Medicine and Health (2022) Vol. 50, Iss. 1
Open Access | Times Cited: 11
Could expanding the covid-19 case definition improve the UK’s pandemic response?
Alex Crozier, Jake Dunning, Selina Rajan, et al.
BMJ (2021), pp. n1625-n1625
Closed Access | Times Cited: 15
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
Clémentine Metzger, Taylor Leroy, Agathe Bochnakian, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0269104-e0269104
Open Access | Times Cited: 5
Mathematical Modeling of COVID-19 Transmission and Intervention in South Korea: A Review of Literature
Hyojung Lee, Sol Kim, Minyoung Jeong, et al.
Yonsei Medical Journal (2022) Vol. 64, Iss. 1, pp. 1-1
Open Access | Times Cited: 8
Limited impact of contact tracing in a University setting for COVID-19 due to asymptomatic transmission and social distancing
Daniel Stocks, Emily Nixon, Adam Trickey, et al.
Epidemics (2023) Vol. 45, pp. 100716-100716
Open Access | Times Cited: 4
Concordance of B‐ and T‐cell responses to SARS‐CoV‐2 infection, irrespective of symptoms suggestive of COVID‐19
Marc F. Österdahl, Eleni Christakou, Deborah Hart, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5217-5224
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top